Neupharma is a young and modern company focused on innovation in the field of rare diseases, particularly cystic fibrosis, a genetic disease that affects about 30,000 people in Europe. Our mission is to offer patients suffering from this disease all the means to improve their health and the quality of their lives; as such we offer not just medications but also specific foods and medical devices. As a matter of fact, we believe that we must fully focus on the needs of the patients: we should treat them especially when their healing is not possible. Neupharma invests a significant amount of its turnover in research, development and innovation to achieve this goal and has entered into important partnerships with international companies with similar goals. Neupharma owns independently developed patents as well as patents developed in collaboration with prestigious Italian universities. Neupharma is based in Imola, a beautiful town not far from Bologna, renowned for its car races, music and the quality of its cuisine.